Herein,
we report the nanoscale visualization of the photochemical
degradation dynamics of MAPbI3 (MA = CH3NH3
+) using infrared scattering scanning near-field
microscopy (IR s-SNOM) combined with a series of complementary analytical
techniques such as UV–vis and FTIR-spectroscopy, XRD, and XPS.
Light exposure of the MAPbI3 films resulted in a gradual
loss of MA+ cations starting from the grain boundaries
at the film surface and slowly progressing toward the center of the
grains and deeper into the bulk perovskite phase. The binary lead
iodide PbI2 was found to be the major perovskite photochemical
degradation product under the experimental conditions used. Interestingly,
the formation of the PbI2 skin over the perovskite grains
resulted in a largely enhanced photoluminescence, which resembles
the effects observed for core–shell quantum dots. The obtained
results demonstrate that IR s-SNOM represents a powerful technique
for studying the spatially resolved degradation dynamics of perovskite
absorbers and revealing the associated material aging pathways.
Herein, we show that thin films of MAPbI 3 , FAPbI 3 , (CsMA)PbI 3 , and (CsMAFA)PbI 3 , where MA and FA are methylammonium and formamidinium cations, respectively, tolerate ultrahigh doses of γ rays approaching 10 MGy without significant changes in their absorption spectra. However, among the studied materials, FAPbI 3 was the only one that did not form metallic lead due to its extreme radiation hardness. Infrared nearfield optical microscopy revealed the radiation-induced depletion of organic cations from the grains of MAPbI 3 and their accumulation at the grain boundaries, whereas FAPbI 3 on the contrary lost FA cations from the grain boundaries. The multication (CsMAFA)PbI 3 perovskite underwent a facile phase segregation to domains enriched with MA and FA cations, which is a principally new radiation-induced degradation pathway. Our findings suggest that the radiation hardness of the rationally designed perovskite semiconductors could go far beyond the impressive threshold of 10 MGy we set herein for FAPbI 3 films, which opens many exciting opportunities for practical implementation of these materials.
Perovskite solar cells represent a highly promising third-generation photovoltaic technology. However, their practical implementation is hindered by low device operational stability, mostly related to facile degradation of the absorber materials under exposure to light and elevated temperatures. Improving the intrinsic stability of complex lead halides is a big scientific challenge, which might be addressed using various “molecular modifiers”. These modifiers are usually represented by some additives undergoing strong interactions with the perovskite absorber material, resulting in enhanced solar cell efficiency and/or operational stability. Herein, we present a derivative of 1,4,6,10-tetraazaadamantane, NAdCl, as a promising molecular modifier for lead halide perovskites. NAdCl spectacularly improved both the thermal and photochemical stability of methylammonium lead iodide (MAPbI3) films and, most importantly, prevented the formation of metallic lead Pb0 as a photolysis product. NAdCl improves the electronic quality of perovskite films by healing the traps for charge carriers. Furthermore, it strongly interacts with the perovskite framework and most likely stabilizes undercoordinated Pb2+ ions, which are responsible for Pb0 formation under light exposure. The obtained results feature 1,4,6,10-tetraazaadamantane derivatives as highly promising molecular modifiers that might help to improve the operational lifetime of perovskite solar cells and facilitate the practical implementation of this photovoltaic technology.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.